摘要
本文在论述了医药产业作为高技术产业所具有的高技术、高投入、高风险以及相对垄断性等特征之后,分析了我国医药市场的营销概况和医药企业的发展现状,对比了我国与发达国家的医药企业在经济规模、市场营销和研究开发(R&D)投入方面所存在的差距 , 提出我国在加入WTO后医药产业对所面临挑战的对策。
After discussing the characteristics of the medicine Hi-Tech industry , such as high technology,high investment,high risk and relative monopoly, we analyse the situation of both medicine market and medicine enterprises in China, look at gap between China and developed countries in the fields of economic scale, marketing and R&D, and raise countermeasures to challenge medicine enterprises in China face after entering WTO.
出处
《南开管理评论》
CSSCI
2001年第1期62-66,共5页
Nankai Business Review
基金
国家自然科学基金!项目号:79730020